GFAP and astrocytoma (excluding glioblastoma): In our own previously published study in which we used RNA sequencing data of 310 patients available at TCGA we do show a strong decrease in general GFAP mRNA levels in grade IV compared to grade II and grade III astrocytoma (Stassen et al., 2017).